Clinical trial
Immune Activity Against CVM Retinitis
NCT00001611 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00001611 |
|---|---|
| Title | Immune Activity Against CVM Retinitis |
| Official title | Efficacy of Elevated CD4 Cell Counts on CMV Retinitis |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Acquired Immunodeficiency Syndrome, Cytomegalovirus Retinitis, HIV Infection |
| Enrollment | 15 |
| Start date | Feb 1, 1997 |
| Completion | Apr 1, 2004 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: